Novo CEO pressed by Senate to cut costs of being overweight, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the business would consider new talks with insurers about the list charges of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. Sanders swiftly condemned https://kethek.com/